92 related articles for article (PubMed ID: 488466)
1. In vivo activity of spleen cells from untreated syngeneic mice against Ehrlich ascites carcinoma.
Jakóbisiak M; Kawiak J; Kawalec M; Kańtoch M; Kamiński M; Rozmysłowicz T
Folia Biol (Praha); 1979; 25(3):169-78. PubMed ID: 488466
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
Fuyama S; Yamamoto H; Fujii Y; Arai S
Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
[TBL] [Abstract][Full Text] [Related]
3. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
Olinescu A; Hristescu S; Mazilu E
Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
[TBL] [Abstract][Full Text] [Related]
4. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
Takei F; Levy JG; Kilburn DG
J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
[TBL] [Abstract][Full Text] [Related]
5. Therapy of leukemia by nonimmune syngeneic spleen cells.
Cheever MA; Greenberg PD; Fefer A
J Immunol; 1980 May; 124(5):2137-42. PubMed ID: 7365249
[TBL] [Abstract][Full Text] [Related]
6. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.
Kawase I; Komuta K; Namba M; Yokota S; Ogura T; Kishimoto S
Cancer Res; 1986 Mar; 46(3):1047-54. PubMed ID: 3510719
[TBL] [Abstract][Full Text] [Related]
7. In vivo suppression of Ehrlich ascites carcinoma by human antibody-dependent splenocytes.
Dobaczewska H
Neoplasma; 1984; 31(2):165-8. PubMed ID: 6717686
[TBL] [Abstract][Full Text] [Related]
8. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
9. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
Paciucci PA; Macphail S; Bach FH; Zarling JM
J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
[TBL] [Abstract][Full Text] [Related]
11. In vivo elimination by specific effector cells of an established syngeneic rat moloney virus-induced sarcoma.
Fernandez-Cruz E; Halliburton B; Feldman JD
J Immunol; 1979 Oct; 123(4):1772-7. PubMed ID: 158055
[TBL] [Abstract][Full Text] [Related]
12. In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. III. Spontaneous and natural cytotoxic effector cells.
Herbert AG; Le Gros GS; Bidawid S; Watson JD
Immunology; 1984 Feb; 51(2):377-85. PubMed ID: 6607213
[TBL] [Abstract][Full Text] [Related]
13. Changes in natural killer cells activity in mice bearing subcutaneously implanted Lewis lung carcinoma.
Budzyński W
Arch Immunol Ther Exp (Warsz); 1984; 32(2):185-9. PubMed ID: 6487051
[TBL] [Abstract][Full Text] [Related]
14. Augmentation by OK-432 of generation of culture-induced killer cells.
Ujiie T
Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231
[TBL] [Abstract][Full Text] [Related]
15. [Study on the improved effect of anti-TCR alpha beta monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms].
Hao J; Liu J; Xie S
Zhonghua Yi Xue Za Zhi; 2001 May; 81(10):593-6. PubMed ID: 11798930
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of in vivo antitumour activity of xenogeneic antiserum by autotransplanted normal spleen cells in mice.
Jakóbisiak M; Kańtoch M; Lasek W; Rozmysłowicz T; Obłakowski P; Dobaczewska H
Eur J Cancer (1965); 1981 Jan; 17(1):77-80. PubMed ID: 7262149
[No Abstract] [Full Text] [Related]
17. Regulation of cytotoxic lymphocyte responses in vitro by alloantigen-activated spleen cells.
Truitt GA; Rich RR; Rich SS
J Immunol; 1977 Jul; 119(1):31-7. PubMed ID: 874322
[TBL] [Abstract][Full Text] [Related]
18. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
Brunda MJ; Taramelli D; Holden HT; Varesio L
J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
[TBL] [Abstract][Full Text] [Related]
19. Natural immunity to grafts of FLD-3 erythroleukemia cells by irradiated mice.
Afifi MS; Bennett M; Kumar V
Nat Immun Cell Growth Regul; 1986; 5(4):200-10. PubMed ID: 2430178
[TBL] [Abstract][Full Text] [Related]
20. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. V. Spleen immunoreactivity and cell mediated cytotoxicity.
Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P
Arch Geschwulstforsch; 1987; 57(4):265-74. PubMed ID: 3118852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
